Spots Global Cancer Trial Database for uterine
Every month we try and update this database with for uterine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma | NCT04814108 | Uterine Serous ... | ZN-c3 | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | NCT03395080 | Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma | Paclitaxel 300mg DKN-01 600mg DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) | NCT02423954 | Advanced Cancer Pancreatic Canc... Renal Cell Canc... Non Small Cell ... Colorectal Carc... Endometrial Uterine | Temsirolimus Irinotecan Irinotecan + ca... nivolumab | 18 Years - | Western Regional Medical Center | |
| Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization | NCT02293447 | Uterine Leiomyo... | Lidocaine per-e... Lidocaine post-... | 18 Years - | University Health Network, Toronto | |
| A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma | NCT04814108 | Uterine Serous ... | ZN-c3 | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
| Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids | NCT01377519 | Uterine Fibroid... | MR Guided Focus... Placebo MR Guid... | 18 Years - 99 Years | University of California, San Francisco | |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors | NCT04681248 | Esophageal Neop... Adenocarcinoma ... GastroEsophagea... Squamous Cell C... Gastric Adenoca... Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma Gastric Cancer | DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer | NCT04586959 | ENDOMETRIAL CAN... | Surgery with UM Surgery without... | 18 Years - 90 Years | Baylor College of Medicine | |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) | NCT02423954 | Advanced Cancer Pancreatic Canc... Renal Cell Canc... Non Small Cell ... Colorectal Carc... Endometrial Uterine | Temsirolimus Irinotecan Irinotecan + ca... nivolumab | 18 Years - | Western Regional Medical Center | |
| A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations | NCT05199584 | Solid Tumors Wi... | ENV-101 (talade... | 18 Years - | Endeavor Biomedicines, Inc. | |
| Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids | NCT01377519 | Uterine Fibroid... | MR Guided Focus... Placebo MR Guid... | 18 Years - 99 Years | University of California, San Francisco | |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | NCT03395080 | Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma | Paclitaxel 300mg DKN-01 600mg DKN-01 | 18 Years - | Leap Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
